Accuray Receives AERB Approval for Sale and Supply of its Radixact(R) X9 System in India

SUNNYVALE, Calif., June 21, 2018 -- (Healthcare Sales & Marketing Network) -- Accuray Incorporated (NASDAQ: ARAY) announced today that the Company has received an Atomic Energy Regulatory Board (AERB) Type Approval for its Radixact® X9 System in India... Devices, Oncology, Regulatory Accuray, Radixact X9, TomoTherapy, radiotherapy
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news